Dalmia

From its establishment in 2000, Dalmia Research and Developement Limited has undergone significant development, evolving into the Dalmia, R & D Group. The organization has transitioned into a Contract Research Organization, concentrating on the primary activities of Pharmaceutical Clinical Trials, Bioequivalence and Bioavailability studies, Pre-Clinical Study, Bioanalytical Solutions, Allied Clinical Research on New Drug Formulations, Testing and Trials on Medical Devices, and Regulatory Services within this sector. We have established connections with top industry networks to deliver comprehensive end-to-end solutions on a global scale.